ITeos Therapeutics Investors

21 investors on Angel Roster list ITeos Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, China and Belgium.

Investors are matched on the company name in their portfolio, so companies that share the name ITeos Therapeutics can appear together.

Investors listed
21
With verified email
33%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 ITeos Therapeutics investors

The most complete profiles first. Showing 21 of 21.

  • Joshua KennedyVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Stephanie A. SirotaVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • John ZhuVerified

    Venture Capital · China

    Health CareWomen FoundedBiotechnologyHealth Diagnostics

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Naveen Yalamanchi

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Piratip Pratumsuwan

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Rebecca Zhu

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedManufacturingBiotechnology

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Roderick Wong

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Sabera Loughran

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Tony Nguyen

    Hedge Fund, Venture Capital, Investor · United States

    Series BAdvertisingHealth CareGeneticsInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Alexandra Tolia

    Private Equity Firm · Belgium

    Health CareGeneticsLife ScienceDiabetes

    Portfolio: Ona Therapeutics, eTheRNA immunotherapies, Indigo Diabetes, Confo Therapeutics and 8 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Norman Zhou

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Bronson CrouchVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyMedical

    Portfolio: Peloton Therapeutics, TCR2, ITeos Therapeutics

    Verified email available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many ITeos Therapeutics investors are on Angel Roster?

Angel Roster lists 21 ITeos Therapeutics investors. 7 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (20), Private Equity Firms (10) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do ITeos Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (7) and Seed (3).

Where are ITeos Therapeutics investors based?

Most are based in the United States (18), China (2) and Belgium (1).

Which companies have ITeos Therapeutics investors backed?

The most-backed portfolio companies among them are TCR2 (12), Cullinan Oncology (10), Syndax Pharmaceuticals (10), Aratana Therapeutics (9) and Oncorus (9).

How do I contact ITeos Therapeutics investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.